Gilead Licenses Nine Generic Drug Companies To Make Remdesivir

By Beth Wang / June 22, 2020 at 3:57 PM
Gilead is licensing nine generic drug companies to make remdesivir to boost supplies of the investigational COVID-19 drug, according to a statement on the company’s website dated Monday (June 22). In the statement, Gilead Chair and CEO Daniel O’Day says he expects to make more than 2 million courses of remdesivir available by the end of the year and “many millions more” by 2021. The company already donated its existing supplies of remdesivir through June, O’Day notes. Gilead donated 940,000...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.